In particular, it has been found that in tumor tissue an increase in the enzyme indoleamine 2,3-dioxygenase (IDO) that regulates the degradation of tryptophan is able to promote the development of an immunosuppressive microenvironment that can inhibit effective antitumor immunological responses [112,113]. The gene discussed is IDO1; the disease is neoplasm.